Chemical Compound

Salbutamol Sulphate Imp. I (EP); Salbutamol Imp. I (EP); Levalbuterol USP Related Compound F; Levalbuterol USP RC F; (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanoSalbutamol Sulphate Imp. I (EP); Salbutamol Imp. I (EP); Levalbuterol USP Related Compound F; Levalbuterol USP RC F; (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanol; Levalbuterol Related Compound F; Salbutamol Impurity I; Salbutamol Sulfate Impurity I; Salbutamol Impurity Il

CAS Registry Number 56796-66-8
返回搜索 申请报价
Salbutamol Sulphate Imp. I (EP); Salbutamol Imp. I (EP); Levalbuterol USP Related Compound F; Levalbuterol USP RC F; (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanoSalbutamol Sulphate Imp. I (EP); Salbutamol Imp. I (EP); Levalbuterol USP Related Compound F; Levalbuterol USP RC F; (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanol; Levalbuterol Related Compound F; Salbutamol Impurity I; Salbutamol Sulfate Impurity I; Salbutamol Impurity Il 结构式
Primary record

Salbutamol Sulphate Imp. I (EP); Salbutamol Imp. I (EP); Levalbuterol USP Related Compound F; Levalbuterol USP RC F; (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanoSalbutamol Sulphate Imp. I (EP); Salbutamol Imp. I (EP); Levalbuterol USP Related Compound F; Levalbuterol USP RC F; (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanol; Levalbuterol Related Compound F; Salbutamol Impurity I; Salbutamol Sulfate Impurity I; Salbutamol Impurity Il

库存
6,947 克
纯度
99.7 %
CAS
56796-66-8

化合物标识与属性

CAS
56796-66-8
PubChem CID
92535
SMILES
CC(C)(C)NCC(C1=CC(=C(C=C1)OCC2=CC=CC=C2)CO)O
Canonical SMILES
CC(C)(C)NCC(O)c1ccc(OCc2ccccc2)c(CO)c1

名称与同义词

  • 4-Benzyl Albuterol
  • 56796-66-8
  • Salbutamol Impurity I
  • Salbutamol EP Impurity I
  • 4-(benzyloxy)-alpha
  • AC1L3OBV
  • RefChem:555969
  • 2092ANO5GJ
  • UNII-2092ANO5GJ
  • AC1Q1MO1
  • 4-Benzyl albuterol, (-)-
  • C20H27NO3
  • EINECS 260-385-8
  • AC1Q573X
  • orb3021473
  • SCHEMBL4667082
  • SCHEMBL29496355
  • CTK8A2610
  • DTXSID90866591
  • KST-1B5906
  • BCP15728
  • CID92535
  • AR-1B9265
  • C20-H27-N-O3
  • MFCD00026273
  • 1-(4-(Benzyloxy)-3-(hydroxymethyl)phenyl)-2-(tert-butylamino)ethanol
  • AKOS024323971
  • AN-5154
  • FB18283
  • Rosiglitazone Impurity I (Pharmeuropa)
  • DS-020054
  • J267.108E
  • SALBUTAMOL IMPURITY I [EP IMPURITY]
  • TL8003669
  • 4-(benzyloxy)-alpha-[[tert-butylamino]methyl]-m-xylene-alpha,alpha'-diol
  • FT-0662669
  • NS00054335
  • 2-(tert-butylamino)-1-[3-(hydroxymethyl)-4-phenylmethoxyphenyl]ethanol
  • A965994
  • SALBUTAMOL SULFATE IMPURITY I [EP IMPURITY]
  • 1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethanol
  • Q27253447
  • 1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol
  • 1-(4-Benzyloxy-3-hydroxymethyl-phenyl)-2-(tert-butylamino)ethanol
  • 1-[4-benzyloxy-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethanol
  • B2694-126103
  • 4-(Benzyloxy)-alpha-((tert-butylamino)methyl)-m-xylene-alpha,alpha'-diol
  • (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanol
  • 1-(4-Benzyloxy-3-hydroxymethyl-phenyl)-2-(tert-butylam ino)ethanol
  • 4-(benzyloxy)-?-[(tert-butylamino)methyl]benzeen-1,3-dimethanol
  • a1-[[(1,1-Dimethylethyl)amino]methyl]-4-(phenylmethoxy)-1,3-benzenedimethanol
  • 1-(4-BENZYLOXY-3-HYDROXYMETHYL-PHENYL)-2-(TERT BUTYLAMINO)ETHANOL
  • 1-(4-BENZYLOXY-3-HYDROXYMETHYL-PHENYL)-2-(TERT. BUTYLAMINO)ETHANOL
  • 584-59-8
  • (+/-)-1-(4-(BENZYLOXY)-3-(HYDROXYMETHYL)PHENYL)-2-(TERT-BUTYLAMINO)ETHANOL
  • (1R)-2-(tert-butylamino)-1-[3-(hydroxymethyl)-4-phenylmethoxyphenyl]ethanol
  • (1RS)-2-[(1,1-DIMETHYLETHYL)AMINO]-1-[3-(HYDROXYMETHYL)-4-BENZYLOXYPHENYL]ETHANOL
  • (S)-1-(4-(benzyloxy)-3-(hydroxymethyl)phenyl)-2-(tert-butylamino)ethan-1-ol
  • |A1-[[(1,1-Dimethylethyl)amino]methyl]-4-(phenylmethoxy)-1,3-benzenedimethanol
  • 1,3-Benzenedimethanol, a1-[[(1,1-dimethylethyl)amino]methyl]-4-(phenylmethoxy)-
  • 3-(Hydroxymethyl)--[[(1,1-dimethylethyl)amino]methyl]-4-(phenylmethoxy)benzenemethanol
  • 3-(Hydroxymethyl)-alpha-[[(1,1-dimethylethyl)amino]methyl]-4-(phenylmethoxy)benzenemethanol
  • 4-benzyl salbutamol;4-Benzyl Albuterol; Rosiglitazone Impurity I (Pharmeuropa)
  • alpha1-(((1,1-Dimethylethyl)amino)methyl)-4-(phenylmethoxy)-1,3-benzenedimethanol
  • alpha1-[[(1,1-Dimethylethyl)amino]methyl]-4-(phenylmethoxy)-1,3-benzenedimethanol
  • (1RS)-2-((1,1-DIMETHYLETHYL)AMINO)-1-(4-(BENZYLOXY)-3-(HYDROXYMETHYL)PHENYL)ETHANOL
  • 1,3-BENZENEDIMETHANOL, .ALPHA.1-(((1,1-DIMETHYLETHYL)AMINO)METHYL)-4-(PHENYLMETHOXY)-
  • 174607-68-2
  • 260-385-8
  • 437982-10-0
  • Salbutamol Sulphate Imp. I (EP); Salbutamol Imp. I (EP); Levalbuterol USP Related Compound F; Levalbuterol USP RC F; (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanoSalbutamol Sulphate Imp. I (EP); Salbutamol Imp. I (EP); Levalbuterol USP Related Compound F; Levalbuterol USP RC F; (1RS)-2-[(1,1-Dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanol; Levalbuterol Related Compound F; Salbutamol Impurity I; Salbutamol Sulfate Impurity I; Salbutamol Impurity Il